Lucid bolsters its senior leadership team
October 3, 2016 |
Lucid Group has had a successful summer attracting top talent to its senior leadership team with the appointment of Shula Sarner (Executive Scientific Director) and Tanya Goodyear (Division Director, Immunology).
Shula began working in medical communications in the USA following a successful research career in academia and the biotech industry in the UK, Germany and the USA. She was involved in strategic medical communications and programmes across a variety of therapeutic areas in the USA, as well as numerous successful global launches. Before returning to the UK in 2015, Shula was the director of scientific services at a large independent medical communications agency, leading scientific strategy and business development across teams, and building the new scientific team. “Coming back to the UK after 13 happy and successful years in America has given me the opportunity to learn about the industry beyond that in the USA. I joined Lucid because of its unique offering and focus on changing patient outcomes, which is ultimately what we all strive for.”
Tanya joins Lucid with 16 years of experience in healthcare communications and medical education. Over her career she has led the strategic development and management of international and domestic-based medical communications programmes. Most recently, Tanya was the director of commercial strategy at inVentiv Medical Communications, and over her 9 years there held various other roles both in the UK and USA. “Lucid immediately felt like the perfect team for me – the passion, innovation and creativity running through everything Lucid does translates into world-leading medical education programmes that really do change behaviour.”
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Lucid Group Appoints Former Pfizer R&D Leader Rod MacKenzie, CMG, PhD, as Board Chair to Drive Next Phase of Global Growth and Innovation
Appointment marks a pivotal step in Lucid’s next phase of growth, strengthening its ability to translate complex science into real-world impact. Lucid’s US Medical Affairs division unveils new proprietary insights…
Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences
Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid…
My Lucid journey from PMW to Head of Medical
Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced…
Listen, learn and lift off
In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the…
Launch excellence
In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines…
Meet The Lucid Group Talent Team
Meet our talent team, they’re here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your…
Extraordinary lives: advancing change in rare diseases (Part 2)
In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so…
Extraordinary lives: advancing change in rare diseases (Part 2)
In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so…
Extraordinary lives: advancing change in rare diseases (Part 1)
Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on…